drugset / Trial / NCT02296099
Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to determine if the administration of liposomal bupivacaine at the completion of a suburethral sling procedure will result in decreased postoperative pain compared to no injection.
Timeline
- Start
- 2014-11
- Primary completion
- 2016-08
- Completion
- 2016-08
Outcome
Met primary endpoint
registry analysis (equivalence test); Liposomal Bupivacaine vs Saline Placebo; p = 0.014 NCT02296099 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |